7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hypertension, Pulmonary D006976 32 associated lipids
Hypertension D006973 115 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Hyperinsulinism D006946 27 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hypercalcemia D006934 13 associated lipids
Hyperalgesia D006930 42 associated lipids
HIV Seropositivity D006679 15 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Hirsutism D006628 3 associated lipids
Hip Fractures D006620 2 associated lipids
Hip Dislocation D006617 1 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hepatitis C D006526 7 associated lipids
Hemophilia A D006467 10 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Hemarthrosis D006395 1 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Heart Failure D006333 36 associated lipids
Graves Disease D006111 6 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Glioma D005910 112 associated lipids
Gingival Recession D005889 2 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Eye Neoplasms D005134 2 associated lipids
Endometriosis D004715 29 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Encephalitis D004660 15 associated lipids
Emphysema D004646 1 associated lipids
Disease Susceptibility D004198 12 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Diarrhea D003967 32 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Dermatomyositis D003882 2 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Dengue D003715 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Thompson SW and Tonge D Bone cancer gain without the pain. 2000 Nat. Med. pmid:10802700
Honore P et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. 2000 Nat. Med. pmid:10802707
Onyia JE et al. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. 2000 J. Bone Miner. Res. pmid:10804015
Malyankar UM et al. Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. 2000 J. Biol. Chem. pmid:10811631
Kanzawa M et al. Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. 2000 Eur. J. Endocrinol. pmid:10822231
Thirunavukkarasu K et al. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. 2000 J. Biol. Chem. pmid:10833509
Günther T and Schinke T Mouse genetics have uncovered new paradigms in bone biology. 2000 Trends Endocrinol. Metab. pmid:10856921
Rani CS and MacDougall M Dental cells express factors that regulate bone resorption. 2000 Mol. Cell Biol. Res. Commun. pmid:10860862
Tsurukai T et al. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. 2000 J. Bone Miner. Metab. pmid:10874596
Hofbauer LC and Heufelder AE Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. 2000 J. Clin. Endocrinol. Metab. pmid:10902778

Table of Content